Related Experiment Video

Updated: May 10, 2026

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
11:04

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism

Published on: September 1, 2014

Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart

Johan Arnlöv1, Erik Ingelsson, Ulf Risérus

  • 1Department of Public Health and Caring Sciences, Section of Geriatrics, Uppsala University, Uppsala, Sweden. johan.arnlov@pubcare.uu.se

European Heart Journal
|December 14, 2004
PubMed

Insights

The Myocardial Performance Index (MPI) is a strong predictor of future congestive heart failure (CHF) in elderly men. High MPI values indicate increased CHF risk, even beyond traditional risk factors.

Area of Science:

  • Cardiology
  • Echocardiography
  • Heart Failure Research

Background:

  • Limited data exists on echocardiographic and Doppler indices predicting congestive heart failure (CHF) in the general population.
  • The Myocardial Performance Index (MPI), also known as the TEI-Doppler index, assesses both left ventricular (LV) systolic and diastolic function.

Purpose of the Study:

  • To evaluate echocardiographic and Doppler indices of cardiac function as predictors of future CHF.
  • To determine if MPI provides prognostic information beyond traditional risk factors for heart failure.

Main Methods:

  • A population-based cohort of 552 seventy-year-old men without baseline CHF or significant valve disease was studied.
  • Eight echocardiographic and Doppler indices were compared as predictors of CHF over a median follow-up of 8.2 years.
  • Multivariable Cox proportional-hazard analysis was used to identify independent predictors of CHF morbidity.

Main Results:

  • High MPI (≥0.91), abnormal LV wall motion score index, and pseudo-normalized/restrictive E/A-ratio pattern independently predicted future CHF.
  • After including traditional CHF risk factors, only a high MPI remained a significant predictor (HR 4.72, p=0.002).

Conclusions:

  • MPI offers significant prognostic information for future CHF risk in elderly men.
  • MPI is a clinically relevant indicator of cardiac function and a valuable tool for assessing CHF risk.
Abstract

More Related Videos

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...